Expression of SEC62 Oncogene in Benign, Malignant and Borderline Melanocytic Tumors—Unmasking the Wolf in Sheep’s Clothing?

SIMPLE SUMMARY: Amplification and overexpression of the SEC62 oncogene was reported in a variety of human cancers and was associated with poor prognosis as well as lymph node and distant metastases. In this study, SEC62 expression was analyzed in benign, borderline, and malignant melanocytic lesions...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller, Cornelia S. L., Pföhler, Claudia, Wahl, Maria, Bochen, Florian, Körner, Sandrina, Kühn, Jan Philipp, Bozzato, Alessandro, Schick, Bernhard, Linxweiler, Maximilian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036965/
https://www.ncbi.nlm.nih.gov/pubmed/33915997
http://dx.doi.org/10.3390/cancers13071645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036965/
https://www.ncbi.nlm.nih.gov/pubmed/33915997
http://dx.doi.org/10.3390/cancers13071645

Ejemplares similares